Submit your Defective Drugs claim details for a free, no obligation case review.
Get Started:
drug_recall bextraThe danger of Bextra use has become the subject of recent concern throughout the nation. The danger of Bextra use on cardiovascular safety has been the focus of these concerns after the recall of a similar drug called Vioxx. Vioxx was recalled because it doubled a patient''s risk of suffering heart problems and stroke after eighteen months of use.
Both Vioxx and Bextra are COX-2 selective pain relieving drugs developed in the 1990s to treat the severe pain associated with osteoarthritis, rheumatoid arthritis, and menstrual cramps. The FDA approved Bextra in November 2001, even after known danger of Bextra use was understood.
The danger of Bextra use was a hot topic at the annual American Heart Association conference of November 2004. Studies presented here indicated that patients who were taking Bextra around the time they underwent cardiac bypass surgery were at a greater risk of suffering cardiovascular complications than were other patients.
This led to reports that Bextra, like Vioxx, posed an increased risk of cardiovascular and stroke side effects. Pfizer, Bextra''s maker, responded by stating that these findings are unconfirmed and unsubstantiated. Both Pfizer and the FDA have disclosed their plans to study the danger of Bextra use on cardiovascular and cerebrovascular health in the near future.
Some common side effects are known to be the danger of Bextra use. These common side effects are usually experienced as problems of the gastrointestinal track. Indigestion, nausea, diarrhea, abdominal pain, and headaches are all common Bextra side effects.
A more serious danger of Bextra use is its potential risk of causing serious skin conditions. Since Bextra''s approval by the FDA in 2001, reports of the danger of Bextra use have shown that patients are at an increased risk for developing Stevens-Johnson syndrome and toxic epidermal necrolysis as a result of taking Bextra. These serious and potentially fatal skin conditions have prompted the FDA and Pfizer to consider adding a black box warning on all patient packaging information to include this serious danger of Bextra use.
Another danger of Bextra use is a patient''s increased risk of suffering serious allergic or anaphylactic reaction as a result of taking this prescription medication. If you are taking Bextra and experience any symptoms of Bextra side effects, you should notify your doctor immediately. The danger of Bextra use on cardiovascular safety is still under review; therefore Bextra may also pose additional cardiovascular risks that have not yet been confirmed.
If you are concerned about the danger of Bextra use, you may wish to contact a medical professional who may be able to help. If you have been injured as a result of taking Bextra, you may want to contact a qualified attorney who can advise you of your rights and options in a case to recover your damages through a civil Bextra lawsuit.
Bextra , the popular cox-2 inhibitor recalled by Pfizer, is the subject of another lawsuit.
Rita Fohne has filed her lawsuit against Pfizer in Madison County, Illinois, seeking ...
The U.S. Food and Drug Administration has started issuing alerts to patients and doctors on its new site Drug Watch. Including emerging drug-safety concerns, as well as dangers presented by drugs prescribed for unapproved uses, the new site is in resp...
After a controversial year of drug recalls, the FDA was under attack for failing to adequately protect consumers from dangerous drugs. Currently, the FDA has the Adverse Event Reporting System, or AERS, to collect voluntary reports of possible reactio...